By Chris Wack
Perrigo Company said Thursday it is buying the branded over-the-counter rights to Prevacid from GlaxoSmithKline.
Perrigo said under the terms of the agreement, it will have the exclusive rights to market, sell and distribute Prevacid 24HR in the U.S. OTC market.
Financial terms of the agreement weren't disclosed.
Prevacid 24HR treats frequent heartburn occurring two or more days a week.
Write to Chris Wack at firstname.lastname@example.org